HEMAXIP IV

Serial Number 85792807
606

Registration Progress

Application Filed
Dec 3, 2012
Under Examination
Jul 16, 2013
Approved for Publication
May 1, 2013
Published for Opposition
May 21, 2013
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: HEMAXIP IV
Previous Owner: The Medicines Company
Classes: 005

Trademark Image

HEMAXIP IV

Basic Information

Serial Number
85792807
Filing Date
December 3, 2012
Published for Opposition
May 21, 2013
Abandonment Date
February 17, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 17, 2014
Classes
005

Rights Holder

The Medicines Company

03
Address
8 Sylvan Way
Parsippany, NJ 07054

Ownership History

The Medicines Company

Original Applicant
03
Parsippany, NJ

The Medicines Company

Owner at Publication
03
Parsippany, NJ

Legal Representation

Attorney
Julia M. Chester

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

14 events
Date Code Type Description Documents
Feb 18, 2014 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Feb 17, 2014 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 16, 2013 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 21, 2013 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 1, 2013 NPUB O NOTICE OF PUBLICATION Loading...
Apr 16, 2013 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Apr 12, 2013 ALIE A ASSIGNED TO LIE Loading...
Mar 22, 2013 CNEA F EXAMINER'S AMENDMENT MAILED Loading...
Mar 22, 2013 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 22, 2013 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 22, 2013 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 21, 2013 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 11, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 6, 2012 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, a platelet inhibiting drug administered intravenously in a hospital setting to prevent blood clotting leading to thrombosis during treatment of acute health conditions
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"IV"